Category:EMA approved in 2023

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 23:38, 1 March 2023 by Jwarner (talk | contribs) (Created page with "Category:EMA approved in the 2020s")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Pages in category "EMA approved in 2023"

The following 12 pages are in this category, out of 12 total.

A

Asparaginase erwinia chrysanthemi-rywn (Rylaze)

D

Decitabine and cedazuridine (Inqovi)

E

F

Futibatinib (Lytgobi)

I

Ivosidenib (Tibsovo)

N

Niraparib and abiraterone (Akeega)

T

Retrieved from "https://hemonc.org/w/index.php?title=Category:EMA_approved_in_2023&oldid=73218"

EMA approved drugs